2018 American Transplant Congress Archives - Page 15 of 211

5:06pm-5:18pm: Ex Vivo-Expanded Human CD19⁺CD73^–CD25⁺CD71⁺TIM-1⁺ B Regulatory Cells Can Prolong Allograft Survival in a Humanized Mouse Model of Skin Transplantation and Are Dependent on TIM-1-Mediated Regulation of STAT3 Signaling

S. Shankar,¹ J. Stolp,^1,2 S. Juvet,^1,3 J. Hester,¹ K. Wood.¹

Concurrent Session: Cellular Therapies and to Promote Tolerance • Room 606/607

5:06pm-5:18pm: A Low Level of De Novo DSA Sialylation is Associated with a Decreased of Allograft Survival in Non-Sensitized Kidney Transplant Recipients

M. Bonnet,^1,2 V. Pernin,^1,3 J-.E. Serre,¹ V. Georgescu,⁴ M. Le Quintrec,^1,2,3 G. Mourad,^1,2 J-.F. Eliaou,^2,5 C. Rene.^2,5

Concurrent Session: Kidney Complications: Antibody & Late Outcomes • Room 4B

5:06pm-5:18pm: A Novel Peripheral Blood mRNA Biomarker Predicts Subclinical Rejection and Kidney Transplant Outcomes

J. Friedewald,¹ S. Kurian,² T. Whisenant,² R. Heilman,³ E. Poggio,⁴ C. Marsh,² P. Baliga,⁵ N. Bridges,⁶ J. Odim,⁶ M. Brown,⁶ D. Ikle,⁷ B. Armstrong,⁷ J. Charette,¹ S. Brietigam,¹ N. Sustento-Reodica,¹ L. Zhao,¹ M. Kandpal,¹ D. Salomon,² M. Abecassis.¹

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes: Clinical • Room 602/603/604

5:06pm-5:18pm: A Phase-I Clinical Trial of Donor-Derived MIC Cell Infusion for the Induction of Donor-Specific Hyporesponsiveness after Living Donor Kidney Transplantation (TOL-1 Study)

C. Morath,¹ A. Schmitt,² C. Kleist,³ V. Daniel,³ G. Opelz,³ C. Süsal,³ F. Fälble,¹ C. Sommerer,¹ L. Wang,² M. Zeier,¹ M. Schmitt,² M. Schaier,¹ P. Terness.³

Concurrent Session: Kidney Immunosuppression: General Considerations - 2 • Room 6A

5:06pm-5:18pm: Cost Impacts of Alternative Kidney Transplant Immunosuppression: A National Cohort Study

K. Lentine,¹ D. Axelrod,² V. Dharnidharka,³ H. Xiao,¹ D. Brennan,⁴ D. Segev,⁴ H. Randall,¹ R. Ouseph,¹ A. Naik,⁵ N. Lam,⁶ T. Alhamad,³ B. Kasiske,⁷ G. Hess,⁸ M. Schnitzler.¹

Concurrent Session: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics - 3 • Room 4C-4

5:06pm-5:18pm: Donor Safety in Obese Patients: 1038 Consecutive Robotic Living Donor Nephrectomies

C. Di Bella,¹ M. Spaggiari,¹ K. Tulla,¹ P. Di Cocco,¹ J. Oberholzer,² I. Tzvetanov,¹ E. Benedetti.¹

Concurrent Session: Kidney Living Donation: Programmatic Issues • Room 6B

5:06pm-5:18pm: HLA-DR4 Matching and Hepatocellular Carcinoma Recurrence after Liver Transplantation

M. Xu, S. Garcia-Aroz, N. Vachharajani, Y. Lin, W. Chapman.

Concurrent Session: Liver: Hepatocellular Carcinoma and Other Malignancies • Room 6C

5:06pm-5:18pm: Impact of Center Volume on Kidney Transplant Outcomes in Contemporary U.S. Transplant Practice

T. Alhamad,¹ F. Abbas,¹ D. Brennan,² A. Malone,¹ J. Wellen,¹ R. Delos Santos,¹ A. Khan,¹ J. Li,¹ R. Rattanavich,¹ K. Lentine.³

Concurrent Session: Kidney: Perioperative Considerations • Room 303

5:06pm-5:18pm: LDLT for High MELD Recipients: A Single Center Experience

S. Ganesh, M. Molinari, T. Amit, H. Christopher, H. Abhinav.

Concurrent Session: Liver: Living Donors and Partial Grafts • Room 608/609

5:06pm-5:18pm: Mechanisms of DEPTOR Function in CD4⁺ T Cell Subsets

J. Wedel,¹ K. Liu,¹ P. Sage,² M. Laplante,³ D. Briscoe.¹

Concurrent Session: New Approaches to Target Regulatory T Cells • Room 618/619/620